Product Description
| Cat Number | PI-090 |
|---|---|
| Category | Peptide |
| Pack Size | 10 mg |
| Description | Dipeptidyl peptidase IV (DPP IV) inhibitor |
| Purity | 98% by tlc |
| Biomarker Target | Dipeptidyl peptidase IV |
| Sequence Three Letter Code | (2S,3S)-2-Amino-3-methyl-1-(thiazolidin-3-yl)pentan-1-one hemifumarate |
| Molecular Formula | C9H18N2OS 1/2C4H4O4 |
| Sl Sequence | (2S,3S)-2-Amino-3-methyl-1-(thiazolidin-3-yl)pentan-1-one hemifumarate |
| Solubility | Soluble in DMSO or in water (up to 20 mg/ml). |
| Appearance | White solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Pederson et al (1998) Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47 1253 PMID: 9703325Pospisilik et al (2002) Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral Ins sensitivity in the VDF Zucker rat. Diabetes 51 2677 PMID: 12196458Wagner et al (2016) Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation. Neuropeptides. 57 21 PMID: 26988064 Related areas_x000D_ All small molecules >All dipeptidyl peptidase IV modulators >All diabetes research categories > |
| Note | The product is for research use only |
Share Item: